L. Tschiderer

发表

Osteoprotegerin and Cardiovascular Events in High‐Risk Populations: Meta‐Analysis of 19 Prospective Studies Involving 27 450 Participants

S. Kiechl, P. Willeit, J. Willeit, 2018, Journal of the American Heart Association.

Association of desphospho-uncarboxylated matrix gla protein with incident cardiovascular disease and all-cause mortality: Results from the prospective Bruneck Study.

S. Kiechl, J. Willeit, P. Santer, 2022, Atherosclerosis.

Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants

S. Kiechl, P. Willeit, J. Willeit, 2017, PloS one.

Immune response to 2-dose BNT162b2 vaccination and risk of SARS-CoV-2 breakthrough infection: The Shieldvacc-2 study

P. Willeit, L. Forer, F. Krammer, 2022, medRxiv.

Application of the Updated Movement Disorder Society Criteria for Prodromal Parkinson's Disease to a Population‐Based 10‐Year Study

W. Poewe, S. Kiechl, P. Willeit, 2021, Movement disorders : official journal of the Movement Disorder Society.

Menopause and cardiovascular risk: insights from analyses of imaging markers.

S. Peters, P. Willeit, L. Tschiderer, 2022, Future cardiology.

The cardiovascular benefits of breastfeeding to mothers

P. Willeit, L. Tschiderer, Sanne A. E. Peters, 2022, Expert review of cardiovascular therapy.

Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Updated Analysis Involving 22,607 Blood Donors Covering the Period October 2021 to April 2022

P. Willeit, H. Schennach, A. Huber, 2022, medRxiv.

Ultra-rapid rollout vaccination with BNT162b2 to reduce SARS-CoV-2 infections in the general population

H. Tilg, P. Willeit, L. Forer, 2022, iScience.

High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants

N. Sattar, S. Kiechl, P. Willeit, 2017, Journal of the American College of Cardiology.

Carotid intima‐media thickness predicts carotid plaque development: Meta‐analysis of seven studies involving 9341 participants

P. Willeit, L. Tschiderer, G. Klingenschmid, 2020, European journal of clinical investigation.

Associations of Serum Dickkopf‐1 and Sclerostin With Cardiovascular Events: Results From the Prospective Bruneck Study

S. Kiechl, P. Willeit, J. Willeit, 2020, Journal of the American Heart Association.

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events

P. Willeit, S. Tsimikas, J. Mcconnell, 2020, Journal of the American Heart Association.

Assessment of Cardiovascular Risk in Women: Progress so Far and Progress to Come

S. Peters, P. Willeit, L. Tschiderer, 2023, International journal of women's health.

Breastfeeding Is Associated With a Reduced Maternal Cardiovascular Risk: Systematic Review and Meta‐Analysis Involving Data From 8 Studies and 1 192 700 Parous Women

S. Peters, P. Willeit, L. O’Keeffe, 2022, Journal of the American Heart Association.

Associations between Physical Activity, Sitting Time, and Time Spent Outdoors with Mental Health during the First COVID-19 Lock Down in Austria

P. Willeit, M. Tully, Lee Smith, 2021, International journal of environmental research and public health.

Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk

S. Yusuf, E. Lonn, D. Grobbee, 2020, Circulation.

High-Sensitivity Cardiac Troponin Concentration and Risk of First-EverCardiovascular Outcomes in154,052 Participants

N. Sattar, S. Kiechl, P. Willeit, 2022 .

Sleep quality and daytime sleepiness in epilepsy: Systematic review and meta-analysis of 25 studies including 8,196 individuals.

P. Willeit, B. Högl, A. Heidbreder, 2021, Sleep medicine reviews.

The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale

G. Bergström, E. Lonn, M. Hanefeld, 2020, Gerontology.

Seroprevalence, Waning and Correlates of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Large-Scale Study of 35,193 Blood Donors Conducted between June 2020 and September 2021

P. Willeit, H. Schennach, L. Tschiderer, 2021, medRxiv.

STROKE-CARD care to prevent cardiovascular events and improve quality of life after acute ischaemic stroke or TIA: A randomised clinical trial

S. Kiechl, P. Willeit, J. Willeit, 2020, EClinicalMedicine.

The dimension of preventable stroke in a large representative patient cohort

S. Kiechl, P. Willeit, J. Willeit, 2019, Neurology.

Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial

K. Becker, P. Willeit, L. Forer, 2023, The Lancet. Microbe.

Association of Intima‐Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta‐Analysis of 20 Prospective Studies

N. Sattar, L. Lind, P. Calder, 2023, Journal of the American Heart Association.

High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants

N. Sattar, S. Kiechl, P. Willeit, 2017, Journal of the American College of Cardiology.

Age at Menopause and the Risk of Stroke: Observational and Mendelian Randomization Analysis in 204 244 Postmenopausal Women

J. Danesh, M. Schulze, A. Tjønneland, 2023, medRxiv.

High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants

N. Sattar, S. Kiechl, P. Willeit, 2017, Journal of the American College of Cardiology.

Intima-media thickness at the near or far wall of the common carotid artery in cardiovascular risk assessment

P. Willeit, H. Gerstein, M. Bots, 2023, European heart journal open.

High-Sensitivity Cardiac Troponin T and Cardiovascular Risk After Ischemic Stroke or Transient Ischemic Attack

P. Willeit, K. Willeit, L. Tschiderer, 2024, JACC: Advances.